Current Biotechnology ›› 2026, Vol. 16 ›› Issue (3): 626-637.DOI: 10.19586/j.2095-2341.2026.0020
• Reviews • Previous Articles Next Articles
Received:2026-01-30
Accepted:2026-03-31
Online:2026-05-25
Published:2026-07-14
CLC Number:
Shaokang WANG. Effects of Chemical Constituents in Schisandra chinensis on Tumor Microenvironment[J]. Current Biotechnology, 2026, 16(3): 626-637.
Table 1 Effects of lignan components in Schisandra chinensis on different tumor proliferation and apoptosis-related mechanisms and target proteins
Table 2 Polysaccharide constituents in Schisandra chinensis and their regulatory mechanisms on the TME
| [1] | BAGHBAN R, ROSHANGAR L, JAHANBAN-ESFAHLAN R, et al.. Tumor microenvironment complexity and therapeutic implications at a glance[J/OL]. Cell Commun. Signal., 2020, 18(1): 59[2026-01-10]. . |
| [2] | YU Y, CUI J. Present and future of cancer immunotherapy: a tumor microenvironmental perspective[J]. Oncol. Lett., 2018, 16(4): 4105-4113. |
| [3] | GALLI F, AGUILERA J V, PALERMO B, et al.. Relevance of immune cell and tumor microenvironment imaging in the new era of immunotherapy[J/OL]. J. Exp. Clin. Cancer Res., 2020, 39(1): 89[2026-01-10]. . |
| [4] | BIANCO A, PERROTTA F, BARRA G, et al.. Prognostic factors and biomarkers of responses to immune checkpoint inhibitors in lung cancer[J/OL]. Int. J. Mol. Sci., 2019, 20(19): 4931[2026-01-10]. . |
| [5] | SHINOHARA S, TAKAHASHI Y, KOMURO H, et al.. New evaluation of the tumor immune microenvironment of non-small cell lung cancer and its association with prognosis[J/OL]. J. ImmunoTherapy Cancer, 2022, 10(4): e003765[2026-01-10]. . |
| [6] | 刘珊,安倩,孙琼,等.中药调控肿瘤微环境研究进展[J].中医肿瘤学杂志,2025,7(4):13-25. |
| LIU S, AN Q, SUN Q, et al.. Research progress in the modulation of tumor microenvironment by traditional Chinese medicine[J]. J. Oncol. Chin. Med., 2025, 7(4): 13-25. | |
| [7] | 国家药典委员会. 中国药典(一部) [S].北京:中国医药科技出版社,2025. |
| [8] | 庄文越,徐铭晨,李正祎.五味子抗肿瘤作用及其相关机制研究进展[J].吉林医药学院学报,2020,41(6):449-451. |
| ZHUANG W Y, XU M C, LI Z Y. Research progress on antitumor effect and related mechanism of Schisandra chinensis [J]. J. Jilin Med. Univ., 2020, 41(6): 449-451. | |
| [9] | 任丽佳,李林,殷放宙,等.五味子抗肿瘤活性成分及作用机制研究进展[J].中国药理学通报,2012,28(1):140-142. |
| REN L J, LI L, YIN F Z, et al.. Review of the current progress on the anti-tumor constituents of Fructus schisandrae chinensis and the underlying mechanisms[J]. Chin. Pharmacol. Bull., 2012, 28(1): 140-142. | |
| [10] | GÜÇ E, POLLARD J W. Redefining macrophage and neutrophil biology in the metastatic cascade[J]. Immunity, 2021, 54(5): 885-902. |
| [11] | DE VISSER K E, JOYCE J A. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth[J]. Cancer Cell, 2023, 41(3): 374-403. |
| [12] | 卜潇,程静,陈瑞兵,等.五味子联苯环辛烯类木脂素药理活性及生物合成研究进展[J/OL].天然产物研究与开发, 2025:1-14[2025-11-23]. . |
| BU X, CHENG J, CHEN R B, et al.. Research progress on biosynthesis and pharmacological activity of dibenzocyclooctadiene lignans from genus Schisandra [J/OL]. Nat. Product Res. Develop., 2025:1-14[2025-11-23]. . | |
| [13] | 胡琴汉,汪伟,罗应彪,等.响应面分析法优化超声波辅助酶法提取南五味子多糖工艺的研究[J].生物技术进展, 2018,8(4):351-357+373. |
| HU Q H, WANG W, LUO Y B, et al.. Optimization of ultrasonic assisted enzymatic extraction of polysaccharide from Kadsura longipedunculata by response surface analysis[J]. Curr. Biotechnol., 2018, 8(4): 351-357+373. | |
| [14] | LIN C H, LIN H W, WU J Y, et al.. Extraction of lignans from the seed of Schisandra chinensis by supercritical fluid extraction and subsequent separation by supercritical fluid simulated moving bed[J]. J. Supercrit. Fluids, 2015, 98: 17-24. |
| [15] | LI C, RU Y J, LIN Q Y, et al.. Schisantherin D from Schisandra chinensis (Turcz.) Baill. exhibits anti-liver fibrosis capacity via modulating ETBR involved signaling, an in vitro and in vivo study[J/OL]. Fitoterapia, 2022, 162: 105290[2026-01-04]. . |
| [16] | SHENG Y, DONG J, WANG R, et al.. The influence of storage conditions on the quality of Schisandra chinensis fruits: a integrated investigation of constituent and antioxidant activity[J/OL]. Heliyon, 2024, 10(11): e32194[2026-01-10]. . |
| [17] | RYBNIKÁŘ M, MALANÍK M, ŠMEJKAL K, et al.. Dibenzocyclooctadiene lignans from Schisandra chinensis with anti-inflammatory effects[J/OL]. Int. J. Mol. Sci., 2024, 25(6): 3465[2026-01-10]. . |
| [18] | DAI X, YIN C, GUO G, et al.. Schisandrin B exhibits potent anticancer activity in triple negative breast cancer by inhibiting STAT3[J]. Toxicol. Appl. Pharmacol., 2018, 358: 110-119. |
| [19] | 沈昆双,孔玲,闫广利,等.五味子防治阿尔茨海默病的作用机制研究进展[J].中南药学,2023,21(2):462-470. |
| SHEN K S, KONG L, YAN G L, et al.. Research progress in the mechanism of Schisandra chinensis in preventing and treating Alzheimer's disease[J]. Cent. South Pharm., 2023, 21(2): 462-470. | |
| [20] | CHEN S, QIN F, YANG Y, et al.. Extraction, purification, structural characterization, and bioactivities of the genus Schisandra polysaccharides: a review[J/OL]. Int. J. Biol. Macromol., 2024, 262(Pt 1): 130257[2026-01-10]. . |
| [21] | KWON K R, ALAM M B, PARK J H, et al.. Attenuation of UVB-induced photo-aging by polyphenolic-rich Spatholobus suberectus stem extract via modulation of MAPK/AP-1/MMPs signaling in human keratinocytes[J/OL]. Nutrients, 2019, 11(6): 1341[2026-01-10]. . |
| [22] | PARK J Y, KIM K H. A randomized, double-blind, placebo-controlled trial of Schisandra chinensis for menopausal symptoms[J]. Climacteric, 2016, 19(6): 574-580. |
| [23] | HONG S H, LI M, JEUNG E B, et al.. Therapeutic effects of Schisandra chinensis on the hyperprolactinemia in rat[J]. Int. J. Oncol., 2017, 50(4): 1448-1454. |
| [24] | 王娇娇,康惠丽,冯石卜,等.南五味子多糖对高糖损伤INS-1细胞及糖尿病小鼠的改善作用[J].中南药学,2024,22(11):2858-2863. |
| WANG J J, KANG H L, FENG S B, et al.. Amelioration of Schisandra sphenanthera polysaccharides on high glucoseinduced damage in INS-1 cells and diabetic mice[J]. Cent. South Pharm., 2024, 22(11): 2858-2863. | |
| [25] | LEE J H, LEE Y Y, LEE J, et al.. Chemical composition, antioxidant, and anti-inflammatory activity of essential oil from omija (Schisandra chinensis (Turcz.) Baill.) produced by supercritical fluid extraction using CO2[J/OL]. Foods, 2021, 10(7): 1619[2026-01-10]. . |
| [26] | THINH B B, THANH V Q, THIN D B, et al.. Chemical composition and antimicrobial activity of the essential oils obtained from the leaves and stems of Schisandra perulata gagnep[J]. J. Essent. Oil Bear. Plants, 2022, 25(4): 773-782. |
| [27] | QIAN X J, ZHANG X L, ZHAO P, et al.. A Schisandra-derived compound schizandronic acid inhibits entry of pan-HCV genotypes into human hepatocytes[J/OL]. Sci. Rep., 2016, 6: 27268[2026-01-10]. . |
| [28] | 金银萍,曲正义,崔丽丽,等.五味子不同部位黄酮和酚酸类成分的含量测定及抗氧化活性[J].中国实验方剂学杂志,2018,24(19):79-84. |
| JIN Y P, QU Z Y, CUI L L, et al.. Quantification of flavonoids and phenols and their antioxidant activities in different parts of Schisandra chinensis [J]. Chin. J. Exp. Tradit. Med. Formulae, 2018, 24(19): 79-84. | |
| [29] | CARDONA-MENDOZA A, FONSECA-BENITEZ A, BUITRAGO D M, et al.. Down-regulation of human papillomavirus E6 oncogene and antiproliferative effect of Schisandra chinensis and Pueraria lobata natural extracts on Hela cell line[J/OL]. J. Ethnopharmacol., 2024, 319: 117225[2026-01-10]. . |
| [30] | 王光杰,张熙.五味子多糖对人脑胶质瘤U251细胞增殖的抑制作用及机制研究[J].现代中西医结合杂志,2020,29(18):1968-1972. |
| WANG G J, ZHANG X. Study on the inhibitory effect and mechanism of Schisandra chinensis polysaccharide on human glioma U251 cell proliferation[J]. Mod. J. Integr. Tradit. Chin. West. Med., 2020, 29(18): 1968-1972. | |
| [31] | 程甜甜,满子腾,李筱琳,等.基于网络药理学与体外实验探讨五味子丙素治疗脑胶质瘤的作用机制[J].现代药物与临床,2025,40(3):564-570. |
| CHENG T T, MAN Z T, LI X L, et al.. Mechanism of action of schisandrin C in treatment of glioma based on network pharmacology and in vitro experiments[J]. Drugs Clin., 2025, 40(3): 564-570. | |
| [32] | 李月灵,王高峰,彭红,等.五味子乙素抑制胃癌SNU-1细胞增殖和转移的作用机制研究[J].中国免疫学杂志,2017,33(12):1815-1818+1827. |
| LI Y L, WANG G F, PENG H, et al.. Research of inhibitory mechanism of salidroside B on proliferation and metastasis of gastric cancer SNU-1 cells[J]. Chin. J. Immunol., 2017, 33(12): 1815-1818+1827. | |
| [33] | 姚佳丽,徐海能,范齐昀,等.五味子丙素体外抗胃癌细胞系AGS的活性[J].温州医科大学学报,2021,51(3):187-191. |
| YAO J L, XU H N, FAN Q Y, et al.. Anti-gastric cancer activity of schisandrin C in AGS[J]. J. Wenzhou Med. Univ., 2021, 51(3): 187-191. | |
| [34] | LI T, ZHANG Y, ZHANG T, et al.. Schisandrin B exerts anticancer effects on human gastric cancer cells through ROS-mediated MAPK, STAT3, and NF-κB pathways[J]. Biocell, 2023, 47(1): 195-204. |
| [35] | WANG Z, YU K, HU Y, et al.. Schisantherin A induces cell apoptosis through ROS/JNK signaling pathway in human gastric cancer cells[J/OL]. Biochem. Pharmacol., 2020, 173: 113673[2026-01-10]. . |
| [36] | 朱彤,饶井芬,刘承一,等.五味子乙素对阿帕替尼抗肝癌细胞的增强作用[J].中国临床药理学杂志,2020,36(11):1503-1506. |
| ZHU T, RAO J F, LIU C Y, et al.. Enhancement of schisandrin B on apatinib against hepatoma[J]. Chin. J. Clin. Pharmacol., 2020, 36(11): 1503-1506. | |
| [37] | 罗梦玉,官鹭,卢山,等.基于铁死亡途径的五味子乙素抗肝癌细胞增殖机制及其微乳增效作用研究[J].中草药,2024,55(13):4411-4422. |
| LUO M Y, GUAN L, LU S, et al.. Mechanism of schisandrin B on inhibiting proliferation of hepatocellular carcinoma cells based on ferroptosis pathway and its microemulsion enhancing effect[J]. Chin. Tradit. Herb. Drugs, 2024, 55(13): 4411-4422. | |
| [38] | ZHANG Z, ZHONG Y, HAN X, et al.. Schisanhenol inhibits the proliferation of hepatocellular carcinoma cells by targeting programmed cell death-ligand 1 via the STAT3 pathways[J]. Anticancer Agents Med. Chem., 2025, 25(10): 697-710. |
| [39] | ZHU P L, LAM D F, LI J K, et al.. Gomisin N exerts anti-liver cancer effects and regulates PI3K-Akt and mTOR-ULK1 pathways in vitro [J]. Biol. Pharm. Bull., 2020, 43(8): 1267-1271. |
| [40] | 傅家财,秦玲莎,杨露,等.五味子乙素对胰腺癌Pan02细胞增殖的抑制作用及其机制[J].吉林大学学报(医学版),2024,50(3):638-646. |
| FU J C, QIN L S, YANG L, et al.. Inhibitory effect of schisandrin B on proliferation of pancreatic cancer Pan02 cells and its mechanism[J]. J. Jilin Univ. Med. Ed., 2024, 50(3): 638-646. | |
| [41] | 曾智锐,雷珊,张金娟,等.五味子甲素对人胰腺癌细胞株As Pc-1增殖、凋亡的影响及其机制[J].山东医药,2019,59(12):1-4. |
| ZENG Z R, LEI S, ZHANG J J, et al.. Effects and mechanism of deoxyschizandrin on proliferation and apoptosis of human pancreatic cancer cells AsPc-1[J]. Shandong Med. J., 2019, 59(12): 1-4. | |
| [42] | 李凤金,李雨欣,胡垚,等.五味子乙素对胰腺癌恶性进展小鼠模型影响及炎症机制[J/OL].中药药理与临床,2025:1-16[2025-11-25].. |
| LI F J, LI Y X, HU Y, et al.. Effect of Schisandrin B on malignant progression of pancreatic cancer in mouse model and its inflammatory mechanism[J/OL]. Pharmacol. Clinics Chin. Materia Medica, 2025:1-16[2025-11-25]. . | |
| [43] | 王子文,刘兆玉.戈米辛G抑制HepG2细胞生长的机制研究[J].中国临床药理学杂志,2022,38(8):768-771. |
| WANG Z W, LIU Z Y. Study on the mechanism of gomisin G inhibiting the growth of HepG2 cells[J]. Chin. J. Clin. Pharmacol., 2022, 38(8): 768-771. | |
| [44] | 刘小东,郑小红,张稳稳.五味子酯乙对肺癌耐紫杉醇A549/Tax细胞的多药耐药逆转作用及机制[J].山东化工,2020,49(14):27-30. |
| LIU X D, ZHENG X H, ZHANG W W. Schisantherin B reverses multidrug resistance of lung cancer A549/Tax cells and its underlying mechanism[J]. Shandong Chem. Ind., 2020, 49(14): 27-30. | |
| [45] | 高庆霞,陈素霞,王红叶,等.五味子乙素联合紫杉醇对非小细胞肺癌细胞上皮-间充质转化的作用[J].生物技术,2023,33(1):102-110. |
| GAO Q X, CHEN S X, WANG H Y, et al.. Role of schisandrin B combined with paclitaxel inhibits to epithelial-mesenchymal transformation of non-small cell lung cancer cells[J]. Biotechnology, 2023, 33(1): 102-110. | |
| [46] | 谭晖,王吉昌,董丹凤,等.五味子酯甲通过抑制CCAT1和PI3K-AKT信号通路抑制肺癌细胞的迁移和侵袭[J].世界中医药,2021,16(13):1966-1971. |
| TAN H, WANF J C, DONG D F, et al.. Schisantherin A inhibits the migration and invasion of lung cancer cells by inhibiting the CCAT1 and PI3K-AKT signaling pathway[J]. World Chin. Med., 2021, 16(13): 1966-1971. | |
| [47] | LIU M, YANG K, QIU H. Exploring the effect of gomisin a on non-small cell lung cancer with network pharmacology, molecular docking, in vitro and in vivo assays[J/OL]. Chem. Biol. Drug Des., 2024, 104(5): e70014[2026-02-20]. . |
| [48] | 赵炜,赵志正.五味子乙素对人乳腺癌细胞MCF-7增殖和Notch-1信号通路的影响[J].中国中医药信息杂志,2019,26(10):55-59. |
| ZHAO W, ZHAO Z Z. Effects of schisandrin B on cell proliferation and Notch-1 signaling pathway in breast cancer cell MCF-7[J]. Chin. J. Inf. Tradit. Chin. Med., 2019, 26(10): 55-59. | |
| [49] | 米慧琼,张英.五味子乙素介导Wnt/β-catenin信号通路诱导乳腺癌MCF-7细胞凋亡的分子机制[J].西部中医药,2020,33(10):37-41. |
| MI H Q, ZHANG Y. Molecular mechanism of schisandrin B inducing the apoptosis of mammary cancer MCF-7 cells through mediating Wnt/β-catenin signaling pathway[J]. West. J. Tradit. Chin. Med., 2020, 33(10): 37-41. | |
| [50] | 朱文芳,林金辉.五味子乙素逆转乳腺癌细胞多柔比星耐药的机制研究[J].浙江中西医结合杂志,2021,31(11):1007-1011. |
| ZHU W F, LIN J H. Role and mechanism of schizandrin B on reversing doxorubicin resistance in breast cancer cells[J]. Zhejiang J. Integr. Tradit. Chin. West. Med., 2021, 31(11): 1007-1011. | |
| [51] | 王玮婷,殷雪琴,夏金娥,等.五味子乙素通过ROS介导内质网应激诱导人乳腺癌MDA-MB-231细胞凋亡的研究[J].药学实践杂志,2021,39(6):499-503+533. |
| WANG W T, YIN X Q, XIA J E, et al.. Schisandrin B induces apoptosis of human breast cancer MDA-MB-231 cells through ROS mediated endoplasmic reticulum stress[J]. J. Pharm. Pract., 2021, 39(6): 499-503+533. | |
| [52] | XU X, RAJAMANICHAM V, XU S, et al.. Corrigendum to "Schisandrin A inhibits triple negative breast cancer cells by regulating Wnt/ER stress signaling pathway" [Biomed. Pharmacother. 115 (2019) 108922[J/OL]. Biomed. Pharmacother., 2022, 149: 112865[2026-01-10]. . |
| [53] | JUNG S, MOON H I, KIM S, et al.. Anticancer activity of gomisin J from Schisandra chinensis fruit[J]. Oncol. Rep., 2019, 41(1): 711-717. |
| [54] | 陈腾祥,梁黎,曾智锐,等.基于Met/PI3K/Akt信号通路研究五味子甲素对人鼻咽癌细胞HONE-1增殖、迁移和侵袭的影响[J].中国药房,2020,31(19):2376-2381. |
| CHEN T X, LIANG L, ZENG Z R, et al.. Study on the effects of deoxyschizandrin on the proliferation, migration and invasion of human nasopharyngeal carcinoma cell HONE-1 via met/PI3K/Akt signaling pathway[J]. China Pharm., 2020, 31(19): 2376-2381. | |
| [55] | 黄胜,龚蕊,刘赣赣,等.五味子甲素对前列腺癌骨转移PC⁃3细胞增殖、迁移和侵袭的影响及作用机制研究[J].实用医学杂志,2021,37(7):851-857. |
| HUANG S, GONG R, LIU G G, et al.. Effect of deoxyschizandrin on proliferation, migration and invasion of PC? 3 cells and its mechanism[J]. J. Pract. Med., 2021, 37(7): 851-857. | |
| [56] | PENG C W, MA P L, DAI H T. Schizandrin A promotes apoptosis in prostate cancer by inducing ROS-mediated endoplasmic reticulum stress and JNK/MAPK signaling activation[J/OL]. Pathol. Res. Pract., 2025, 269: 155889[2026-01-10]. . |
| [57] | 戴国梁,贡涛,李豫,等.五味子乙素通过VEGF/PI3K/Akt信号通路抑制人结肠癌细胞SW620的增殖和迁移[J].中国药学杂志,2018,53(14):1186-1191. |
| DAI G L, GONG T, LI Y, et al.. Effect of schisandrin B on proliferation and migration of human SW620 colon cancer cell via VEGF/PI3K/Akt signaling pathway[J]. Chin. Pharm. J., 2018, 53(14): 1186-1191. | |
| [58] | 姜恩平,李贺,于春艳,等.五味子乙素通过p38MAPK信号通路对结肠癌SW480细胞凋亡和侵袭的影响[J].吉林大学学报(医学版),2015,41(4):675-679. |
| JIANG E P, LI H, YU C Y, et al.. Influence of schisandrin B in apoptosis and invasion of SW480 cells via p38MAPK signaling pathway[J]. J. Jilin Univ. Med. Ed., 2015, 41(4): 675-679. | |
| [59] | KEE J Y, HAN Y H, MUN J G, et al.. Gomisin A suppresses colorectal lung metastasis by inducing AMPK/p38-mediated apoptosis and decreasing metastatic abilities of colorectal cancer cells[J/OL]. Front. Pharmacol., 2018, 9: 986[2026-01-10]. . |
| [60] | HAN Y H, MUN J G, JEON H D, et al.. Gomisin A ameliorates metastatic melanoma by inhibiting AMPK and ERK/JNK-mediated cell survival and metastatic phenotypes[J/OL]. Phytomedicine, 2020, 68: 153147[2026-01-10]. . |
| [61] | CHEN J, ZHANG L, PU Y, et al.. Schisandrin B inhibits cell viability and malignant progression of melanoma cells via Wnt/β-catenin signaling pathway[J]. Anti Cancer Agents Med. Chem., 2023, 23(15): 1765-1773. |
| [62] | BI Y, FU Y, WANG S, et al.. Schizandrin A exerts anti-tumor effects on A375 cells by down-regulating H19[J/OL]. Rev. Bras. De Pesquisas Med. E Biol., 2019, 52(10): e8385[2026-01-10]. . |
| [63] | LEE K, AHN J H, LEE K T, et al.. Deoxyschizandrin, isolated from Schisandra berries, induces cell cycle arrest in ovarian cancer cells and inhibits the protumoural activation of tumour-associated macrophages[J/OL]. Nutrients, 2018, 10(1): 91[2026-01-10]. . |
| [64] | SONG A, DING T, WEI N, et al.. Schisandrin B induces HepG2 cells pyroptosis by activating NK cells mediated anti-tumor immunity[J/OL]. Toxicol. Appl. Pharmacol., 2023, 472: 116574[2026-01-10]. . |
| [65] | DING Y, GUO N, JIANG Y, et al.. Establishment of cluster of differentiation 20 immobilized cell membrane chromatography for the screening of active antitumor components in traditional Chinese medicine[J/OL]. J. Chromatogr. A, 2024, 1721: 464845[2026-01-10]. . |
| [66] | 彭朝阳,贾廷印,李好朝,等.五味子乙素对肝癌细胞凋亡、侵袭及血管新生的调节作用[J].中国免疫学杂志,2019,35(3):287-291. |
| PENG C Y, JIA T Y, LI H C, et al.. Schisandrin B regulates apoptosis, invasion and angiogenesis of liver cancer cells[J]. Chin. J. Immunol., 2019, 35(3): 287-291. | |
| [67] | SUN R, ZHAI R, MA C, et al.. WITHDRAWN: the anti-growth and anti-metastasis effects of schisandrin B on hepatocarcinoma cells in vitro and in vivo [J]. Biochem. Biophys. Res. Commun., 2017: S0006-S291X(17)31134-8[2026-01-04]. . |
| [68] | 李妍,侯月,牟星蔚,等.北五味子在胸主动脉瘤发生发展中作用机制的网络药理学和分子对接技术分析[J].吉林大学学报(医学版),2022,48(2):414-425. |
| LI Y, HOU Y, MU X W, et al.. Network pharmacology and molecular docking analysis on mechanism of Schisandrae chinensis Fructus in occurrence and development of thoracic aortic aneurysm[J]. J. Jilin Univ. Med. Ed., 2022, 48(2): 414-425. | |
| [69] | 吴赛男.五味子乙素对人宫颈癌Siha细胞增殖和迁移的影响及机制研究[D].吉林:北华大学,2021. |
| [70] | 黄晓东,路倩,范红艳,等.五味子多糖对人结肠癌HT29细胞增殖的抑制作用及其机制[J].中国老年学杂志,2015,35(22):6337-6338. |
| HUANG X D, LU Q, FAN H Y, et al.. Inhibitory effect of Schisandra chinensis polysaccharide on proliferation of human colon cancer HT29 cells and its mechanism[J]. Chin. J. Gerontol., 2015, 35(22): 6337-6338. | |
| [71] | 姜恩平,王卓,陈建光,等.ERK信号途径介导五味子多糖对Hela细胞凋亡和侵袭的作用[J].时珍国医国药,2015,26(8):1892-1895. |
| JIANG E P, WANG Z, CHEN J G, et al.. ERK signaling pathway mediates the effect of Schisandra polysaccharide on apoptosis and invasion of Hela cells[J]. Lishizhen Med. Mater. Med. Res., 2015, 26(8): 1892-1895. | |
| [72] | 蒋师,张兴强.五味子多糖通过抑制DUSP4/ERK信号通路对人胃癌HGC27细胞凋亡的影响[J].西部中医药,2020,33(1):41-44. |
| JIANG S, ZHANG X Q. Effects of Schisandra polysaccharide on human gastric cancer HGC27 cells apoptosis through inhibiting DUSP4/ERK signaling pathway[J]. West. J. Tradit. Chin. Med., 2020, 33(1): 41-44. | |
| [73] | CHEN Y, SHI S, WANG H, et al.. A homogeneous polysaccharide from fructus Schisandra chinensis (Turcz.Baill). induces mitochondrial apoptosis through the Hsp90/AKT signalling pathway in HepG2 cells[J/OL]. Int. J. Mol. Sci., 2016, 17(7): 1015[2026-01-10]. . |
| [74] | ZHAO T, FENG Y, LI J, et al.. Schisandra polysaccharide evokes immunomodulatory activity through TLR 4-mediated activation of macrophages[J]. Int. J. Biol. Macromol., 2014, 65: 33-40. |
| [75] | XU C, LI Y, DONG M, et al.. Inhibitory effect of Schisandra chinensis leaf polysaccharide against L5178Y lymphoma[J]. Carbohyd. Polym., 2011, 88(1): 21-25. |
| [76] | LIANG J, HUANG Y X, ZHU X H, et al.. Structural identification, rheological properties and immunological receptor of a complex galacturonoglucan from fruits of Schisandra chinensis (Turcz.) Baill[J/OL]. Carbohydr. Polym., 2024, 346: 122644[2026-01-10]. . |
| [77] | LIU S J, QU H M, REN Y P. SCP, a polysaccharide from Schisandra chinensis, induces apoptosis in human renal cell carcinoma Caki-1 cells through mitochondrial-dependent pathway via inhibition of ERK activation[J]. Tumour Biol., 2014, 35(6): 5369-5374. |
| [78] | QU H M, LIU S J, ZHANG C Y. Antitumor and antiangiogenic activity of Schisandra chinensis polysaccharide in a renal cell carcinoma model[J]. Int. J. Biol. Macromol., 2014, 66: 52-56. |
| [79] | 唐泽波,刘永娇,陈默然,等.五味子多糖对SHG-44细胞产生血管内皮生长因子和Caspase-8的影响[J].中国老年学杂志,2018,38(23):5796-5798. |
| TANG Z B, LIU Y J, CHEN M R, et al.. Effect of Schisandra chinensis polysaccharide on the production of vascular endothelial growth factor and Caspase-8 in SHG-44 cells[J]. Chin. J. Gerontol., 2018, 38(23): 5796-5798. | |
| [80] | JEONG M, KIM H M, KIM H J, et al.. Kudsuphilactone B, a nortriterpenoid isolated from Schisandra chinensis fruit, induces caspase-dependent apoptosis in human ovarian cancer A2780 cells[J]. Arch. Pharmacal Res., 2017, 40(4): 500-508. |
| [81] | GONG J E, KIM J E, LEE S J, et al.. Anti-cancer effects of α-cubebenoate derived from Schisandra chinensis in CT26 colon cancer cells[J/OL]. Mol. Basel Switz., 2022, 27(3): 737[2026-01-10]. . |
| [82] | 吴程,谢李华,郑晨华,等.基于网络药理学探讨槲皮素治疗肺癌的分子作用机制[J].福建医科大学学报,2022,56(3):195-203+230. |
| WU C, XIE L H, ZHENG C H, et al.. Molecular mechanism of quercetin in the treatment of lung cancer based on network pharmacology[J]. J. Fujian Med. Univ., 2022, 56(3): 195-203+230. | |
| [83] | 梁兰兰,张磊磊,李琼璘,等.槲皮素对胶质瘤细胞增殖和侵袭的干预作用及其机制[J].营养学报,2023,45(3):279-286. |
| LIANG L L, ZHANG L L, LI Q L, et al.. Intervention effect of quercetin on proliferation and invasion abilities of glioma cells and its related mechanism[J]. Acta Nutr. Sin., 2023, 45(3): 279-286. | |
| [84] | 刘心悦.基于分子对接研究四种植物精油体外抑制癌细胞增殖活性机制[D].长沙:中南林业科技大学,2022. |
| [85] | 牛莉萍.北五味子挥发油生物活性的研究及其诱导肝癌HepG2细胞凋亡机制的初步探讨[D].武汉:华中师范大学,2011. |
| [86] | 翟晓艺,刁钟琪,陈异,等.基于单细胞RNA-seq和批量RNA-seq数据构建乳腺癌患者的肿瘤相关成纤维细胞和相关预后特征的风险模型[J].生物技术进展,2025,15(6):1094-1107. |
| ZHAI X Y, DIAO Z Q, CHEN Y, et al.. Risk modeling of cancer-associated fibroblasts and associated prognostic features in breast cancer patients based on single-cell RNA-seq and bulk RNA-seq data[J]. Curr. Biotechnol., 2025, 15(6): 1094-1107. |
| [1] | Mengjie DONG, Peiwen FAN, Ruozheng WANG. Transcriptomic Analysis of the Role of NFIA in HER2-positive Breast Cancer Brain Metastasis [J]. Current Biotechnology, 2026, 16(3): 706-718. |
| [2] | Jinxiang ZHANG, Xiaodan CAO, Wenlei LI, Junjun DAI, Yan YU, Hanmei XU. Study on Optimizing Antibody Screening Strategy by Using pH Characteristics of Tumor Microenvironment [J]. Current Biotechnology, 2026, 16(1): 170-177. |
| [3] | Xiaoyi ZHAI, Zhongqi DIAO, Yi CHEN, Wenjia GUO. Risk Modeling of Cancer-associated Fibroblasts and Associated Prognostic Features in Breast Cancer Patients Based on Single-cell RNA-seq and Bulk RNA-seq Data [J]. Current Biotechnology, 2025, 15(6): 1094-1107. |
| [4] | Xiaoya LIU, Shuomin ZHANG, Peng ZHENG, Rui MA, Chaojun ZHANG. Role and Mechanisms of DBNDD1 in Colorectal Cancer Development [J]. Current Biotechnology, 2025, 15(4): 726-734. |
| [5] | Xiaoyi ZHAI, Haiyue ZHANG, Wenjia GUO, Xiaogang DONG. Research Progress of Cancer-associated Fibroblasts in Breast Cancer [J]. Current Biotechnology, 2025, 15(4): 636-644. |
| [6] | Yeerkenbieke BUERLAN, Wenjia GUO, Xiaogang DONG. Advances on the Function of POSTN in Tumor Microenvironment [J]. Current Biotechnology, 2024, 14(2): 205-210. |
| [7] | Pengxiao ZHANG, Nian HU. The Research Progress on Action Mechanism of Melanoma Immunotherapy [J]. Current Biotechnology, 2023, 13(6): 900-906. |
| [8] | Yongchao LI, Zhao YANG. Status and Countermeasures of Bispecific Antibody Drugs [J]. Current Biotechnology, 2023, 13(3): 353-358. |
| [9] | LIU Shibo1, WU Hao1, HONG Jiao2, LIU Mengyu1, YAO Mawulikplimi Adzavon1, ZHAO Pengxiang1*. Advances in the Study of Inflammation-tumor Transformation in Ocular Diseases [J]. Curr. Biotech., 2020, 10(3): 234-241. |
| [10] | LIN Li-sha1,2, ZHANG Shen1,2, CHAN Yue-lin3, WANG Zeng-kun3, LIN He-. A Review of Chemical Constituents and Medicinal Function of Mesona chinensis Benth [J]. Curr. Biotech., 2013, 3(6): 448-52. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
